Let's touch on a few of the key items in the quarter. We delivered adjusted EBITDA growth in each of our operating segments. We exceeded the midpoint of our adjusted EBITDA outlook. One more time we beat consensus estimates for revenue, EBITDA and importantly EPS. We had a clear and meaningful improvement in our hospital volumes. USPI delivered a very strong quarter with solid increases in surgical volumes. And Conifer, despite all the uncertainties and changes with our future, generated double-digit EBITDA growth, a 540 basis points of margin improvement, reflecting the continued ongoing work to tighten the cost and service structure of the company.